The Global Sales Officer, CBD of Procter & Gamble is Exercising Options

By Carrie Williams

Today it was reported that the Global Sales Officer, CBD of Procter & Gamble (PGResearch Report), Jeffrey Schomburger, exercised options to sell 47,582 PG shares at $63.05 a share, for a total transaction value of $5.09M.

In addition to Jeffrey Schomburger, 26 other PG executives reported Sell trades in the last month. Following Jeffrey Schomburger’s last PG Sell transaction on May 01, 2019, the stock climbed by 3.2%.

See today’s analyst top recommended stocks >>

Based on Procter & Gamble’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $16.46 billion and quarterly net profit of $2.75 billion. In comparison, last year the company earned revenue of $16.28 billion and had a net profit of $2.51 billion. Currently, Procter & Gamble has an average volume of 3.19M. PG’s market cap is $271.2B and the company has a P/E ratio of 25.73.

Based on 12 analyst ratings, the analyst consensus is Moderate Buy with an average price target of $107.40, reflecting a 0.1% upside.

The insider sentiment on Procter & Gamble has been negative according to 129 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.